Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:49 AM
Ignite Modification Date:
2025-12-24 @ 11:49 AM
NCT ID:
NCT04946461
Eligibility Criteria:
Inclusion Criteria:
1. Participant is aged between 18 - 60 years at time of diagnosis
2. Participant is diagnosed with ADHD according to the DSM 5 criteria
3. Participant started pharmacotherapy treatment with dex or lisdex but no real preference for the type of amphetamine exists according to practitioner
4. Participant is able to provide written informed consent
5. Participant is able and willing to comply with the study protocol
Exclusion Criteria:
1. No diagnosis for ADHD
2. Currently other psychopharmacotherapy treatment than dex or lisdex
3. Currently other psychopharmacotherapy parallel to dex or lisdex
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT04946461
Study Brief:
Protocol Section:
NCT04946461